Cullinan therapeutics to participate in fireside chat at td cowen 5th annual oncology innovation summit

Cambridge, mass., may 24, 2024 (globe newswire) -- cullinan therapeutics, inc. (nasdaq: cgem), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that nadim ahmed, chief executive officer and jeffrey jones, md, mba, chief medical officer, will participate in a fireside chat at the td cowen 5th annual oncology innovation summit: insights for asco & eha, being held virtually on may 28 and 29, 2024.
COWN Ratings Summary
COWN Quant Ranking